Biotechnology News

November 1, 2012

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today reported results for the quarter ended September 30, 2012. Highlights: Net revenues of $5.0 billion, compared to $4.3 billion in the third quarter of 2011, an...

November 1, 2012

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE):   ($ in millions, except per share amounts)       Third-Quarter       Year-to-Date   2012         2011(4)       Change   2012         2011(4)       Change Reported Revenues $ 13,976 $ 16,609 (16...

November 1, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix launches Axiom Biobank Array, a flexible and high-powered solution, for genotyping large sample collections such as those screened at biobanks, genome centers, and core labs

November 1, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum undertakes a strategic strengthening of its sales force in the U.S., implementing a structure of six geographic regions and realigning existing resources to enhance presence.

November 1, 2012

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) today reported third-quarter 2012 financial results, including revenue from its first commercial product, Jakafi® (ruxolitinib), which was approved by the U.S. Food & Drug...

November 1, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions announces its financial results for the third quarter and nine months ended September 30, 2012.

November 1, 2012

WOBURN, Mass.--(BUSINESS WIRE)--ArQule reports results of operations for the fiscal quarter and nine months ended September 30, 2012.

November 1, 2012

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) today reported financial results for its second quarter of fiscal 2013, which ended Sept. 30, 2012, and the company provided improved financial expectations for its fiscal year 2013, which will...

November 1, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, today announced the signing of a distribution agreement with...

November 1, 2012

SANTA ANA, Calif.--(BUSINESS WIRE)--Irvine Scientific, a leading cell culture media/ medical device company for more than 40 years, announced their newly launched cell therapy PRIME-XV™ product portfolio as part of the company’s commitment to...

November 1, 2012

DUBLIN--(BUSINESS WIRE)--ICON plc announces Third Quarter Results

November 1, 2012

LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular”) (NYSE MKT: IMUC) provided an update on recent 2012 achievements and anticipated milestones following the closing of its follow-on financing. Commented John S. Yu,...

November 1, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Vitrolife AB (STO:VITR) Continued strong growth and resolution to distribute Transplantation Third quarter Group, including discontinuing operations Sales growth was 17 percent in local currency...

October 31, 2012

CALABASAS, Calif.--(BUSINESS WIRE)--Medical Diagnostic Associates, a Medical Corporation (MDIA), a national leader in providing Network Diagnostic Imaging (MRI and CT) and Electrodiagnostic (EMG and NCV) services, announces the expansion and...

October 31, 2012

SAN FRANCISCO--(BUSINESS WIRE)--FibroGen, Inc., today announced that two abstracts relating to FG-4592, its oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) clinical candidate for the treatment of anemia in chronic kidney...

October 31, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Announces Publication of LEMTRADA(TM) (alemtuzumab) Pivotal Studies in The Lancet

October 31, 2012

LIMERICK, Pa.--(BUSINESS WIRE)--Teleflex Launches New ARROW FlexBlock Continuous Peripheral Nerve Block Catheter

October 31, 2012

LIMERICK, Pa.--(BUSINESS WIRE)--Teleflex Announces Quarterly Dividend

October 31, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Affymax, Inc. (Nasdaq: AFFY) today announced that it will host a teleconference and webcast with management to provide a general business overview, as well as to discuss its third quarter 2012 financial results...

October 31, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) will report its third quarter 2012 financial results on November 7, 2012, after close of market.

October 31, 2012

MILAN--(BUSINESS WIRE)--Sorin Group Announces Third Quarter Results

October 31, 2012

DES MOINES, Iowa--(BUSINESS WIRE)--Americans for Choice and Competition in Agriculture reacts to progress made by agriculture industry stakeholders in developing a framework for the seed marketplace.

October 31, 2012

WESTBOROUGH, Mass.--(BUSINESS WIRE)--Ameridose today announced it will commence a voluntary recall of any unexpired products remaining in circulation. This action is voluntary, and represents an expansion of our cooperation with the U.S. Food and...

October 31, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: The Extraordinary General Meeting of Vitrolife (STO:VITR) held on September 24 adopted a resolution regarding a private placement of EUR 1.352.315 in order to partly finance the acquisition of...

October 31, 2012

UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News: The number of shares and votes in Orexo (STO:ORX) has changed as a result of the exercise of warrants. Today, the last trading day of the month, there are in total 29,922,909 shares and votes in...

October 31, 2012

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Due to the effects of Hurricane Sandy on the Eastern seaboard, CardioNet, Inc. (NASDAQ:BEAT) is postponing the release of its Third Quarter 2012 financial results to Monday, November 5 at 4 PM Eastern Time. The...

October 31, 2012

WASHINGTON--(BUSINESS WIRE)--For the first time, researchers can visualize in 3-D the stresses induced by flowing blood in an embryonic heart. The technique promises to provide new insight into how and why heart defects develop.

October 31, 2012

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Medical Imaging, Inc. (Lantheus or the Company) and two world leaders in producing medical isotopes have agreed to work together to help ensure supplies of potentially life-saving nuclear medicine...

October 31, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals today announced that it filed the resubmission of its Lymphoseek® NDA to the FDA in response to the CRL received in September 2012.

October 31, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis announces financing

October 31, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis updates preliminary data from India study

October 31, 2012

BOSTON & GENEVA--(BUSINESS WIRE)--PHT Corporation, world's leading provider of innovative technology systems used to collect patient-driven eData for clinical research, appoints Dr. Susan Dallabrida Senior Scientific Advisor

October 31, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that, nearly half of surveyed gastroenterologists, unaided, note that they are using...

October 31, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced the initiation of the Phase 3 CB-5945 opioid-induced constipation (OIC) Ascent program with the enrollment of the first patient in the long-term safety...

October 31, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Asahi Kasei Pharma America initiated its Phase 3 clinical trial of ART-123, a novel, recombinant, human soluble thrombomodulin alpha, for the treatment of severe sepsis with coagulopathy.

October 31, 2012

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen Ltd. (NASDAQ: CGEN), announced today the discovery and initial validation of two new drug target candidates for monoclonal antibody (mAb) cancer therapy. These new candidates have been shown to be...

October 31, 2012

WOBURN, Mass.--(BUSINESS WIRE)--Courtagen's new genetic test, epiSEEK™, provides the complete sequence of 327 genes that have been reported in association with epilepsy phenotypes and nonspecific seizure disorders.

October 31, 2012

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Anja Moellman, Senior Project Director for Theorem Clinical Research will present on the opportunities and challenges of clinical research in China at the Partnerships in Clinical Trials conference.

October 31, 2012

SAN CARLOS, Calif.--(BUSINESS WIRE)--Natera today announced that data from a clinical study published in Prenatal Diagnosis demonstrate the ability of the company’s non-invasive prenatal screening test to detect chromosomal abnormalities from...

October 31, 2012

WESTON, Mass. & STOCKHOLM, Sweden--(BUSINESS WIRE)--Biogen Idec (NASDAQ: BIIB) and Swedish Orphan Biovitrum (Sobi) (STO: SOBI) today announced positive results from A-LONG, a clinical study that evaluated a new long-lasting clotting factor...

October 31, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that a Phase 2 clinical trial evaluating tenofovir alafenamide fumarate (TAF; formerly referred to as GS-7340), an investigational novel prodrug of...

October 31, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aileron Therapeutics, Inc., a biopharmaceutical company developing and advancing a revolutionary class of drugs called Stapled Peptides, today announced the company’s participation in several upcoming scientific...

October 31, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem will present preclinical data on its programs in FAK and PI3K/mTOR at the EORTC-NCI-AACR meeting, November 6-9, 2012 in Dublin, Ireland.

October 31, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in the 2012 Brean Capital Life Sciences Summit on November 7, 2012 in New York City. In addition, Infinity will be presenting at the Lazard...

October 31, 2012

PARIS--(BUSINESS WIRE)--Mobile payment, identification or urban mobility smart technologies are taking an increasing part of everyday life. Exhibitors from the smart technology industry will make the most of CARTES 2012 Exhibition and Conference...

October 31, 2012

JERUSALEM--(BUSINESS WIRE)--Yissum Research and Development Company of the Hebrew University of Jerusalem, the technology transfer company of the Hebrew University, announced today the inception of its subsidiary, Integra Holdings, a holding...

October 31, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will host a live webcast of its quarterly conference call at 8:30 a.m. (ET) on Wednesday, November 7, 2012. Harvey J. Berger, M.D., chairman and...

October 31, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE: EBS) announced today the initiation of a Phase 1b study (Protocol 16009) of TRU-016 in combination with rituximab for patients with previously untreated chronic lymphocytic...

October 31, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (NASDAQ:SGEN) today announced that its collaborator, Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, announced that the European...